Cargando…
miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer
Carcinoma of the prostate is the most common cancer in men. Treatment of aggressive prostate cancer involves a regiment of radical prostectomy, radiation therapy, chemotherapy and hormonal therapy. Despite significant improvements in the last decade, the treatment of prostate cancer remains unsatisf...
Autores principales: | Nabavi, Noushin, Saidy, Nur Ridzwan Nur, Venalainen, Erik, Haegert, Anne, Parolia, Abhijit, Xue, Hui, Wang, Yuwei, Wu, Rebecca, Dong, Xin, Collins, Colin, Crea, Francesco, Wang, Yuzhuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481412/ https://www.ncbi.nlm.nih.gov/pubmed/28642484 http://dx.doi.org/10.1038/s41598-017-03731-8 |
Ejemplares similares
-
The long noncoding RNA
HORAS5 mediates castration‐resistant prostate cancer survival by activating the androgen receptor transcriptional program
por: Parolia, Abhijit, et al.
Publicado: (2019) -
Framework of Intrinsic Immune Landscape of Dormant Prostate Cancer
por: Wong, Nelson K. Y., et al.
Publicado: (2022) -
The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo
por: Parolia, Abhijit, et al.
Publicado: (2015) -
Metabolic heterogeneity signature of primary treatment-naïve prostate cancer
por: Lin, Dong, et al.
Publicado: (2017) -
Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer
por: Lin, Dong, et al.
Publicado: (2014)